Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer

Y Wang, C Zhao, L Chang, R Jia, R Liu, Y Zhang… - …, 2019 - thelancet.com
Abstract Background Circulating tumor DNA (ctDNA) isolated from plasma contains genetic
mutations that can be representative of those found in primary tumor tissue DNA. These …

Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect

G Corso, J Figueiredo, C La Vecchia… - Journal of medical …, 2018 - jmg.bmj.com
Recent studies have reported germline CDH1 mutations in cases of lobular breast cancer
(LBC) not associated with the classical hereditary diffuse gastric cancer syndrome. A …

Gastric adenocarcinoma: pathomorphology and molecular pathology

M Werner, KF Becker, G Keller, H Höfler - Journal of cancer research and …, 2001 - Springer
Two types of gastric adenocarcinoma can be distinguished histopathologically: the diffuse
and the intestinal type. Molecular pathology supports this theory by showing differences in …

Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome …

E Fewings, A Larionov, J Redman… - The lancet …, 2018 - thelancet.com
Background Germline pathogenic variants in the E-cadherin gene (CDH1) are strongly
associated with the development of hereditary diffuse gastric cancer. There is a paucity of …

CDH1‐related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling

I Kluijt, EJM Siemerink, MGEM Ausems… - … journal of cancer, 2012 - Wiley Online Library
CDH1 mutation carriers have a strongly increased risk of developing gastric cancer (GC)
and lobular breast cancer (LBC). Clinical data of GC cases and surgical and histological …

Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred

C Oliveira, MC Bordin, N Grehan, D Huntsman… - Human …, 2002 - Wiley Online Library
Abstract The International Gastric Cancer Linkage Consortium (IGCLC) predicted that up to
25% of families fulfilling the criteria for hereditary diffuse gastric cancer (HDGC) would …

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications

WM Rogers, E Dobo, JA Norton… - The American journal …, 2008 - journals.lww.com
Hereditary diffuse gastric cancer is a rare autosomal dominant cancer susceptibility
syndrome caused by germline E-cadherin (CDH1) mutations in 40% of cases with a high …

Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management

G Suriano, S Yew, P Ferreira, J Senz, P Kaurah… - Clinical cancer …, 2005 - AACR
Purpose: To identify germ line CDH1 mutations in hereditary diffuse gastric cancer (HDGC)
families and develop guidelines for management of at risk individuals. Experimental Design …

[HTML][HTML] E-cadherin dysfunction in gastric cancer-Cellular consequences, clinical applications and open questions

P Carneiro, MS Fernandes, J Figueiredo, J Caldeira… - FEBS letters, 2012 - Elsevier
E-cadherin plays a major role in cell–cell adhesion and inactivating germline mutations in its
encoding gene predispose to hereditary diffuse gastric cancer. Evidence indicates that aside …

Prophylactic total gastrectomy for familial gastric cancer

FR Lewis, JD Mellinger, A Hayashi, D Lorelli… - Surgery, 2001 - Elsevier
Background. An autosomal dominant syndrome of diffuse gastric cancer has been reported
with germline mutations in the E-cadherin (CDH1) gene and has been identified in …